Advanced Coats’ disease treated with intravitreal bevacizumab combined with laser vascular ablation
Victor M Villegas,1 Aaron S Gold,1 Audina M Berrocal,2 Timothy G Murray11Ocular Oncology and Retina, Miami, FL, USA; 2Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, FL, USAPurpose: To evaluate the impact of intravitreal bevacizumab c...
Guardado en:
Autores principales: | Villegas VM, Gold AS, Berrocal AM, Murray TG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c5cf4e3f2494456841ebf345e1f90cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab
por: Cavalcante ML, et al.
Publicado: (2014) -
Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats’ Disease
por: Nowara M, et al.
Publicado: (2021) -
Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
por: Palejwala NV, et al.
Publicado: (2014) -
Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
por: Houston SK, et al.
Publicado: (2013) -
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
por: Shah NV, et al.
Publicado: (2012)